102 related articles for article (PubMed ID: 17661207)
1. Soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) is decreased in lung cancer patients showing progression: a pilot study.
Yilmaztepe A; Ulukaya E; Zik B; Yagci A; Sevimli A; Yilmaz M; Erdogan BB; Koc M; Akgoz S; Karadag M; Tokullugil A
Cancer Invest; 2007 Aug; 25(5):322-7. PubMed ID: 17661207
[TBL] [Abstract][Full Text] [Related]
2. Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types.
Ilhan N; Ilhan N; Deveci F
Clin Biochem; 2004 Sep; 37(9):840-5. PubMed ID: 15329326
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
[TBL] [Abstract][Full Text] [Related]
4. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy.
Naumnik W; Izycki T; Swidzińska E; Ossolińiska M; Chyczewska E
Oncol Res; 2007; 16(9):445-51. PubMed ID: 18074680
[TBL] [Abstract][Full Text] [Related]
6. [The relativity of vascular endothelium growth factor receptor-1 and preeclampsia].
Zou CL; Liu XH; Yue BM; Fu JH; He GL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):765-8. PubMed ID: 17037747
[TBL] [Abstract][Full Text] [Related]
7. Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients.
Kikuchi S; Obata Y; Yagyu K; Lin Y; Nakajima T; Kobayashi O; Kikuichi M; Ushijima R; Kurosawa M; Ueda J
Cancer Sci; 2011 Apr; 102(4):866-9. PubMed ID: 21219538
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
[TBL] [Abstract][Full Text] [Related]
9. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
Banerjee S; Pancholi S; A'hern R; Ghazoui Z; Smith IE; Dowsett M; Martin LA
Clin Cancer Res; 2008 May; 14(9):2656-63. PubMed ID: 18451229
[TBL] [Abstract][Full Text] [Related]
10. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity.
Pieh C; Agostini H; Buschbeck C; Krüger M; Schulte-Mönting J; Zirrgiebel U; Drevs J; Lagrèze WA
Br J Ophthalmol; 2008 May; 92(5):689-93. PubMed ID: 18408080
[TBL] [Abstract][Full Text] [Related]
11. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates.
Boutsikou T; Malamitsi-Puchner A; Economou E; Boutsikou M; Puchner KP; Hassiakos D
Early Hum Dev; 2006 Apr; 82(4):235-9. PubMed ID: 16337100
[TBL] [Abstract][Full Text] [Related]
12. Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome.
Mouawad R; Spano JP; Comperat E; Capron F; Khayat D
Eur J Cancer; 2009 May; 45(8):1407-14. PubMed ID: 19157860
[TBL] [Abstract][Full Text] [Related]
13. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
14. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.
Lamszus K; Ulbricht U; Matschke J; Brockmann MA; Fillbrandt R; Westphal M
Clin Cancer Res; 2003 Apr; 9(4):1399-405. PubMed ID: 12684411
[TBL] [Abstract][Full Text] [Related]
15. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
[TBL] [Abstract][Full Text] [Related]
16. Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury.
Perkins GD; Roberts J; McAuley DF; Armstrong L; Millar A; Gao F; Thickett DR
Thorax; 2005 Feb; 60(2):153-8. PubMed ID: 15681505
[TBL] [Abstract][Full Text] [Related]
17. Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study.
Seet RC; Chow AW; Quek AM; Chan YH; Lim EC
Int J Infect Dis; 2009 Sep; 13(5):e248-53. PubMed ID: 19261502
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism.
Emanuele E; Orsi P; Barale F; di Nemi SU; Bertona M; Politi P
Clin Biochem; 2010 Feb; 43(3):317-9. PubMed ID: 19850021
[TBL] [Abstract][Full Text] [Related]
19. Comparison of serum VEGF and its soluble receptor sVEGFR1 with serum cell-free DNA in patients with breast tumor.
El Tarhouny S; Seefeld M; Fan AX; Hahn S; Holzgreve W; Zhong XY
Cytokine; 2008 Oct; 44(1):65-9. PubMed ID: 18691902
[TBL] [Abstract][Full Text] [Related]
20. Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients.
Guo Q; Carrero JJ; Yu X; Bárány P; Qureshi AR; Eriksson M; Anderstam B; Chmielewski M; Heimbürger O; Stenvinkel P; Lindholm B; Axelsson J
Nephrol Dial Transplant; 2009 Nov; 24(11):3468-73. PubMed ID: 19561151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
